Align Technology, Inc. — Wall Street Analyst Estimates & Price Targets

ALGN

NASDAQHealthcareMedical - DevicesCIK 0001097149aligntech.comAbout ALGN

Last close · Oct 16, 2026147.31−2.03 (−1.36%)

Market cap$10.5B

4 firms' latest targets, last 90 days: median $182.00 ($162.00–$215.00), 24% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker

Each firm's latest target

last 90 days · 4 firms

Date	Firm	Target	Previous	Change	Vs price then	Vs price now
2026-10-15	Baird	$162.00	$218.00	▼ 26%	+12%	+10%
2026-10-14	Leerink Partners	$215.00	—	—	+50%	+46%
2026-10-09	Stifel	$175.00	$210.00	▼ 17%	+24%	+19%
2026-07-23	UBS	$189.00	$185.00	▲ 2%	+13%	+28%

Consensus estimates

revenue and EPS by fiscal year · reported years marked

FY	Revenue	YoY	EPS	YoY	Revenue range	EPS range	Analysts
2022reported	$3.7B	-6%	$4.61	-52%	est. $3.7B+0%	est. $7.03	3
2023reported	$3.9B	+3%	$5.81	+26%	est. $3.8B+1%	est. $8.37	9
2024reported	$4.0B	+4%	$5.62	-3%	est. $4.0B+0%	est. $9.33	11
2025reported	$4.0B	+1%	$5.65	+1%	est. $4.0B+0%	est. $10.20	11
2026	$4.2B	+3%	$11.26	+10%	$4.1B–$4.2B	$10.96–$11.67	12
2027	$4.3B	+4%	$12.43	+10%	$4.2B–$4.4B	$11.69–$12.82	12
2028	$4.5B	+5%	$13.58	+9%	$4.2B–$4.7B	$12.35–$15.27	11
2029	$4.9B	+8%	$15.35	+13%	$4.7B–$5.0B	$14.67–$15.75	5

A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

The analysts at a glance

$182.00median target, 24% above the last close

Firms with a target · last 90 days: 4
Lowest – highest target: $162.00 – $215.00
Current grades of 11 firms: positive / neutral / negative: 7 / 4 / 0
Upgrades / downgrades · 12 months: 2 / 2
Consensus revenue growth · next 3 FY: +4% a year

Current grades

each firm's latest · 11 firms

As of	Firm	Grade
2026-10-15	Baird	“Neutral”
2026-10-14	Leerink Partners	“Outperform”
2026-10-09	Stifel	“Buy”
2026-10-05	Evercore ISI	“In Line”
2026-07-23	UBS	“Neutral”
2026-04-30	Mizuho	“Outperform”
2026-04-24	Morgan Stanley	“Equal Weight”
2026-04-21	Piper Sandler	“Overweight”
2026-03-17	Barclays	“Overweight”
2026-02-09	HSBC	“Buy”
2026-02-05	Wells Fargo	“Overweight”

Grade changes

last 24 months · 8

Date	Firm	Grade
2026-10-15	Baird	“Outperform” → “Neutral” downgrade
2026-10-05	Evercore ISI	“Outperform” → “In Line” downgrade
2026-03-17	Barclays	“Equal Weight” → “Overweight” upgrade
2026-02-09	HSBC	“Hold” → “Buy” upgrade
2025-10-10	Jefferies	“Buy” → “Hold” downgrade
2025-07-31	Morgan Stanley	“Overweight” → “Equal Weight” downgrade
2025-04-25	HSBC	“Buy” → “Hold” downgrade
2025-01-06	Leerink Partners	“Market Perform” → “Outperform” upgrade

33 older than 24 months

2024-06-04	OTR Global	“Positive” → “Mixed” downgrade
2023-12-11	Goldman Sachs	“Neutral” → “Sell” downgrade
2023-10-27	UBS	“Buy” → “Neutral” downgrade
2023-09-14	OTR Global	“Mixed” → “Positive” upgrade
2023-03-31	OTR Global	“Mixed” → “Positive” upgrade
2023-02-03	Goldman Sachs	“Sell” → “Neutral” upgrade
2022-07-28	Goldman Sachs	“Buy” → “Sell” downgrade
2022-01-31	UBS	“Neutral” → “Buy” upgrade
2021-07-09	Stephens & Co.	“Equal Weight” → “Overweight” upgrade
2021-04-22	Berenberg	“Hold” → “Buy” upgrade
2021-01-04	Evercore ISI	“In Line” → “Outperform” upgrade
2020-07-29	Berenberg	“Buy” → “Hold” downgrade
2020-07-23	Barclays	“Overweight” → “Equal Weight” downgrade
2020-07-20	Bank of America	“Neutral” → “Underperform” downgrade
2019-07-25	Evercore ISI	“Outperform” → “In Line” downgrade
2019-02-14	UBS	“Buy” → “Neutral” downgrade
2018-04-19	Morgan Stanley	“Overweight” → “Equal Weight” downgrade
2018-01-19	Stephens & Co.	“Overweight” → “Equal Weight” downgrade
2017-07-28	Bank of America	“Neutral” → “Buy” upgrade
2017-04-28	Baird	“Neutral” → “Outperform” upgrade
2016-10-03	Baird	“Overweight” → “Neutral” downgrade
2015-04-21	Morgan Stanley	“Equal Weight” → “Overweight” upgrade
2015-01-30	JMP Securities	“Market Outperform” → “Market Perform” downgrade
2015-01-02	Baird	“Neutral” → “Outperform” upgrade
2014-10-20	Goldman Sachs	“Neutral” → “Buy” upgrade
2014-10-20	Credit Suisse	“Neutral” → “Outperform” upgrade
2014-04-07	Barrington Research	“Market Perform” → “Outperform” upgrade
2013-10-18	Cantor Fitzgerald	“Hold” → “Buy” upgrade
2013-10-04	Baird	“Outperform” → “Neutral” downgrade
2013-05-28	Jefferies	“Buy” → “Hold” downgrade
2013-05-20	Barrington Research	“Outperform” → “Market Perform” downgrade
2013-01-31	Stephens & Co.	“Equal Weight” → “Overweight” upgrade
2013-01-03	Morgan Stanley	“Underperform” → “Equal Weight” upgrade

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.